Follow
Ayalur Raghu Subbalakshmi
Title
Cited by
Cited by
Year
A computational systems biology approach identifies SLUG as a mediator of partial Epithelial-Mesenchymal Transition (EMT)
AR Subbalakshmi, S Sahoo, K Biswas, MK Jolly
Cells Tissues Organs 211 (6), 689-702, 2022
432022
A non-genetic mechanism involving the integrin β4/Paxillin axis contributes to chemoresistance in lung cancer
A Mohanty, A Nam, A Pozhitkov, L Yang, S Srivastava, A Nathan, X Wu, ...
Iscience 23 (9), 2020
34*2020
NFATc Acts as a Non-Canonical Phenotypic Stability Factor for a Hybrid Epithelial/Mesenchymal Phenotype
AR Subbalakshmi, D Kundnani, K Biswas, A Ghosh, SM Hanash, ...
Frontiers in Oncology 10, 1-12, 2020
342020
KLF4 induces mesenchymal–epithelial transition (MET) by suppressing multiple EMT-inducing transcription factors
AR Subbalakshmi, S Sahoo, I McMullen, AN Saxena, SK Venugopal, ...
Cancers 13 (20), 5135, 2021
232021
The fundamentals of phenotypic plasticity
S Sahoo, AR Subbalakshmi, MK Jolly
Phenotypic Switching, 1-21, 2020
19*2020
Phenotypic heterogeneity in circulating tumor cells and its prognostic value in metastasis and overall survival
K Saxena, AR Subbalakshmi, MK Jolly
EBioMedicine 46, 4-5, 2019
172019
The ELF3 transcription factor is associated with an epithelial phenotype and represses epithelial-mesenchymal transition
AR Subbalakshmi, S Sahoo, P Manjunatha, S Goyal, VA Kasiviswanathan, ...
Journal of Biological Engineering 17 (1), 17, 2023
152023
Tumor hybrid cells: nature and biological significance
MS Tretyakova, AR Subbalakshmi, ME Menyailo, MK Jolly, EV Denisov
Frontiers in cell and developmental biology 10, 814714, 2022
152022
Lineage plasticity in cancer: the tale of a skin-walker
AP Thankamony, AR Subbalakshmi, MK Jolly, R Nair
Cancers 13 (14), 3602, 2021
152021
Mapping spatiotemporal heterogeneity in tumor profiles by integrating high-throughput imaging and omics analysis
PA Patkulkar, AR Subbalakshmi, MK Jolly, S Sinharay
ACS omega 8 (7), 6126-6138, 2023
92023
Biophysical and biochemical attributes of hybrid epithelial/mesenchymal phenotypes
AR Subbalakshmi, B Ashraf, MK Jolly
Physical Biology 19 (2), 025001, 2022
82022
Cancer: More than a geneticist’s Pandora’s box
K Saxena, AR Subbalakshmi, P Kulkarni, MK Jolly
Journal of Biosciences 47 (2), 21, 2022
62022
Emerging biomarkers and molecular targets for precision medicine in cervical cancer
P Garg, M Krishna, AR Subbalakshmi, S Ramisetty, A Mohanty, P Kulkarni, ...
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 189106, 2024
12024
A Multistep Tumor Growth Model of High-Grade Serous Ovarian Carcinoma Identifies Hypoxia-Associated Signatures
MH More, SS Varankar, RR Naik, RD Dhake, P Ray, RM Bankar, AM Mali, ...
Cells Tissues Organs, 1-17, 2022
12022
Leveraging Cancer Phenotypic Plasticity for Novel Treatment Strategies
S Ramisetty, AR Subbalakshmi, S Pareek, T Mirzapoiazova, D Do, ...
Journal of Clinical Medicine 13 (11), 3337, 2024
2024
Cancer through the Lens of Evolution and Ecology
JA Somarelli, NA Johnson
CRC Press, 2024
2024
Dynamical systems biology approach to identify mediators of the Epithelial-Hybrid-Mesenchymal spectrum
AR Subbalakshmi
2023
Unraveling the dangerous duet between cancer cell plasticity and drug resistance
N Chatterjee, B Pulipaka, AR Subbalakshmi, MK Jolly, R Nair
Computational and Systems Oncology 3 (3), e1051, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–18